Social economic costs and health-related quality of life in patients with amyotrophic lateral sclerosis in Spain

References

• Borasio GD, Miller RG. Clinical characteristics and management of ALS. Seminar in Neurology. 2001; 21: 155–66
   PubMed Web of Science ®Google Scholar
• Perestelo-Pérez L, Duran E, Baena N, Gravila D, González M, Arizo V. Estimación de la mínima prevalencia detectada de las enfermedades espinocerebelosas y de la esclerosis lateral amiotrófica en España a partir del CMBD. Gac Sanit. 2004; 18(Suppl 3)66
   Google Scholar
• Damiano A, Patrick D, Guzmán G, Gawel M, Gelinas D, Natter H, et al. Measurement of health-related quality of life in patients with amyotrophic lateral sclerosis in clinical trials of new therapies. Med Care. 1999; 37: 15–26
   PubMed Web of Science ®Google Scholar
• Mitsumoto H, Rabkin JG. Palliative care for patients with amyotrophic lateral sclerosis: “prepare for the worst and hope for the best”. JAMA. 2007; 11;298: 207–16
   Google Scholar
• Kiebert G, Green C, Murphy C, Mitchell J, O'Brien M, Burrell A, et al. Patients’ health-related quality of life and utilities associated with different stages of amyotrophic lateral sclerosis. J Neurol Sci. 2001; 191: 87–93
   PubMed Web of Science ®Google Scholar
• Simmons Z, Bremer BA, Robbins RA, Walsh SM, Fischer S. Quality of life in ALS depends on factors other than strength and physical function. Neurology. 2000; 55: 388–92
   PubMed Web of Science ®Google Scholar
• Robbins RA, Simmons Z, Bremer BA, Walsh SM, Fischer S. Quality of life in ALS is maintained as physical function declines. Neurology. 2001; 56: 442–4
   PubMed Web of Science ®Google Scholar
• Gauthier A, Vignola A, Calvo A, Cavallo E, Moglia C, Sellitti L, et al. A longitudinal study on quality of life and depression in ALS patient-caregiver couples. Neurology. 2007; 68: 923–6
   PubMed Web of Science ®Google Scholar
• Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Methods for the economic valuation of health care programmes2nd edn. Oxford University Press, New York 1997
   Google Scholar
• Hodgson T, Meiners M. Cost-of-illness methodology: a guide to assessment practices and procedures. Millbank Mem Fund Q. 1982; 60: 429–91
   Google Scholar
• Max W, Rice D, Mackenzie E. The lifetime cost of injury. Inquiry. 1990; 27: 332–43
   PubMed Web of Science ®Google Scholar
• SOIKOS. Base de datos de costes sanitarios SOIKOS. Barcelona: SOIKOS. 2001.
   Google Scholar
• MR Gold, Siegel, JE, Russell, LB, Weinstein, MC. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
   Google Scholar
• McDaid D. Estimating the costs of informal care for people with Alzheimer's disease: methodological and practical challenges. Int J Geriatr Psychiatry. 2001; 16: 400–5
   PubMed Web of Science ®Google Scholar
• Mishan E. Evaluation of life and limb: a theoretical approach. J Polit Econ. 1971; 79: 687–705
   Web of Science ®Google Scholar
• López-Bastida J, Serrano-Aguilar P, Duque B. The economic costs of traffic accidents in Spain. J Trauma. 2004; 56: 883–9
   PubMedGoogle Scholar
• Koopmanschap MA, Rutten FFH, van Ineveld BM, van Roijen L. The friction cost method for measuring indirect cost of disease. J Health Econ. 1995; 14: 171–89
   PubMed Web of Science ®Google Scholar
• Instituto Nacional de Estadística. Encuesta de Estructura Salarial. 2002a. Available at URL:, , www.ine.es/prensa/np347.pdf. (accessed 2007 Oct 13).
   Google Scholar
• Instituto Nacional de Estadística. Encuesta de Población Activa. 2002b. Available at URL:, , www.ine.es/daco/daco42/daco4211/epa0402.pdf. (accessed 2007 Oct 13).
   Google Scholar
• Brooks R. EuroQol: the current state of play. Health Policy. 1996; 37: 53–72
   PubMed Web of Science ®Google Scholar
• Badia X, Schiaffino A, Alonso J, Herdman M. Using the EuroQol 5D in the Catalan general population: feasibility and construct validity. Qual Life Res. 1998; 7: 311–22
   PubMed Web of Science ®Google Scholar
• Servicio Canario de la Salud. Encuesta de Salud de Canarias. 2004. Santa Cruz de Tenerife: Consejería de Sanidad del Gobierno de Canarias; 2005. Available at:, , http://www.gobiernodecanarias.org/sanidad/scs/1/plansalud/istac/estadisticas/salud_2004/salud2004.html. (accessed 2007 February 13).
   Google Scholar
• Dolan P. Modelling valuations for EuroQol health states. Med Care. 1997; 35: 1095–1108
   PubMed Web of Science ®Google Scholar
• Badia X, Roset M, Montserrat S, Herdman M, Segura A. The Spanish version of EuroQol: a description and its applications. European Quality of Life scale. Med Clin (Barc) 1999; 112(Suppl 1)79–85
   PubMed Web of Science ®Google Scholar
• Corcia P, Meininger V. Management of amyotrophic lateral sclerosis. Drugs. 2008; 68: 1037–48
   PubMed Web of Science ®Google Scholar
• López-Bastida J, Oliva J, Perestelo-Pérez L, Serrano-Aguilar P. Determinants of health care costs in ambulatory patients living with HIV/AIDS. Value Health. 2005; 8: 23
   Google Scholar
• López-Bastida J, Serrano-Aguilar P, Montón F. The economic burden of stroke in Spain. Value Health. 2003; 6: 615
   Google Scholar
• López-Bastida J, Perestelo Pérez L, Montón-Álvarez F, Serrano Aguilar P. Socioeconomic costs and health-related quality of life in patients with degenerative cerebellar ataxia in Spain. Movement Disorder. 2008; 23: 212–7
   PubMedGoogle Scholar
• López-Bastida J, Serrano-Aguilar P, Perestelo-Pérez L, Oliva-Moreno J. Socioeconomic costs and quality of life with Alzheimer's disease in the Canary Islands, Spain. Neurology. 2006; 67: 2186–91
   PubMed Web of Science ®Google Scholar
• Green C, Kiebert G, Murphy C, Mitchell JD, O'Brien M, Burrell A, Leigh PN. Patients’ health-related quality-of-life and health state values for motor neuron disease/amyotrophic lateral sclerosis. Quality of Life Research. 2003; 12: 565–74
   PubMed Web of Science ®Google Scholar
• Jenkinson C, Hobart J, Chandola T, Fitzpatrick R, Peto V, Swash M, et al. Use of the short form health survey (SF-36) in patients with amyotrophic lateral sclerosis: tests of data quality, score reliability, response rate and scaling assumptions. Journal of Neurology. 2002; 249: 178–83
   PubMed Web of Science ®Google Scholar